Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.
Metrics to compare | ANLN | Peers Peers - average of corresponding metrics from companies closely matching ANLN: LUPIN, SUPRIYA, ACUTAAS, ORCHPHARMA, AUROPHARMA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANLNPeersSector |
---|---|---|---|---|
P/E Ratio | 32.9x | 24.3x | −0.7x | |
PEG Ratio | −6.99 | 0.33 | 0.00 | |
Price/Book | - | 3.3x | 2.6x | |
Price / LTM Sales | 5.6x | 3.0x | 3.4x | |
Upside (Analyst Target) | - | 13.6% | 35.5% | |
Fair Value Upside | Unlock | 10.6% | 3.3% | Unlock |